Diagnostic Testing & Emerging Technologies (1 yr) ASCP Special
Innovation and rapid uptake are feeding the growth of diagnostic testing — what do these changes mean for you and your organization?
Each month, G2’s Diagnostic Testing & Emerging Technologies gives you the latest information and unique perspectives on where diagnostic testing is headed.
Covering the important innovations, new products, manufacturers, markets and end-user applications, each monthly issue provides an unbeatable blend of news, insider analysis, statistics, and forecasts
Your subscription to G2’s Diagnostic Testing & Emerging Technologies delivers:
- Analysis of the latest trends in esoteric lab testing
- Identification of hot new tests and the value they create
- Details on mergers, acquisitions and alliances impacting the industry
- Forecasts for specific test volumes, and overall markets
- New uses for established tests and new licensing decisions
Plus, you’ll uncover the strategies that individual IVD concerns are implementing now to win specific markets, and which sectors have the most potential for long term growth.
What does Diagnostic Testing & Emerging Technologies mean for IVD firm leaders, investors, and practitioners? Critical business knowledge that informs your planning.
Each edition of “DTET” gives you all the relevant insight from inside the diagnostic testing industry. G2’s exclusive “Diagnostic Stock Index” gives you the relative strength of the equity market for 19 IVD company stocks. In each issue, DTET’s “Inside the Diagnostics Industry” takes you on a detailed exploration of a critical issue, company or individual that has major impact on the testing industry, and the “G2 Insider” identifies the next big thing to hit the market.
Subscribe now by purchasing above or by calling Customer Service at 888-729-2315 (8am – 5pm ET).
For multi-user/multi-location pricing, please contact Andrea at 888-729-2315 or via email at firstname.lastname@example.org.